Lipocine
LPCN
#9573
Rank
NZ$45.77 M
Marketcap
$8.56
Share price
6.16%
Change (1 day)
106.46%
Change (1 year)

Revenue for Lipocine (LPCN)

Revenue in 2024 (TTM): NZ$8.04 Million

According to Lipocine's latest financial reports the company's current revenue (TTM ) is NZ$8.21 Million. In 2023 the company made a revenue of -NZ$4.51 Million a decrease over the revenue in the year 2022 that were of NZ$0.78 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Lipocine from 2012 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) NZ$8.04 M-278.5%
2023 -NZ$4.51 Million-672.42%
2022 NZ$0.78 M-96.67%
2021 NZ$23.63 M
2020 N/A-100%
2019 NZ$0.24 M-61.61%
2018 NZ$0.63 M
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NZ$3.93 B 47,814.69%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.69 B 81,340.10%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$36.92 M 349.25%๐Ÿ‡บ๐Ÿ‡ธ USA